SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019370
Filing Date
2023-11-29
Accepted
2023-11-28 21:31:38
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20230930x10q.htm   iXBRL 10-Q 1974148
2 EX-31.1 cycc-20230930xex31d1.htm EX-31.1 14613
3 EX-31.2 cycc-20230930xex31d2.htm EX-31.2 15145
4 EX-32.1 cycc-20230930xex32d1.htm EX-32.1 5076
5 EX-32.2 cycc-20230930xex32d2.htm EX-32.2 5145
  Complete submission text file 0001558370-23-019370.txt   8280015

Data Files

Seq Description Document Type Size
6 EX-101.SCH cycc-20230930.xsd EX-101.SCH 42144
7 EX-101.CAL cycc-20230930_cal.xml EX-101.CAL 34485
8 EX-101.DEF cycc-20230930_def.xml EX-101.DEF 227982
9 EX-101.LAB cycc-20230930_lab.xml EX-101.LAB 333082
10 EX-101.PRE cycc-20230930_pre.xml EX-101.PRE 317494
57 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20230930x10q_htm.xml XML 1804313
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 231448228
SIC: 2834 Pharmaceutical Preparations